CytoDyn (OTCMKTS:CYDY) Stock Price Crosses Below 50 Day Moving Average of $0.17

CytoDyn Inc. (OTCMKTS:CYDY)’s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.17 and traded as low as $0.14. CytoDyn shares last traded at $0.15, with a volume of 1,476,035 shares changing hands.

CytoDyn Stock Up 7.9 %

The firm has a market capitalization of $148.93 million, a price-to-earnings ratio of -3.00 and a beta of 0.25. The business’s fifty day moving average is $0.17 and its 200 day moving average is $0.18.

CytoDyn (OTCMKTS:CYDY) last issued its quarterly earnings results on Monday, April 15th. The biotechnology company reported ($0.01) EPS for the quarter.

About CytoDyn

CytoDyn Inc, a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer.